 |
Marc Hurlbert, Ph.D.
Dr. Marc Hurlbert is a national leader and recognized change-agent in philanthropic grant making. He currently serves as Executive Director of the Avon Foundation for Women and in a few short years has made substantial impact in breast cancer, fostering collaboration and collegiality among groups working in the field. In his role at Avon, Dr. Hurlbert oversees the global Avon Breast Cancer Crusade, and the Foundation’s $35+ million annual grant-making budget, develops overall strategy, sets funding guidelines, manages review committees, and monitors the progress of grant recipients. The Avon Foundation and Avon Products has raised and awarded more than $725 million to support women’s causes since 1955.
Dr. Hurlbert was elected by his peers to serve as the Chair (2010, 2011) of the Health Research Alliance, an alliance of 47 member nonprofit organization’s who collectively award $1.6-billion in annual health research grants to 5,500 research investigators. He also serves as Chair of Columbia University-New York Presbyterian Hospital Health Sciences Advisory Council Cancer Committee and is a member of the Working Group of the NIEHS/NCI Breast Cancer and the Environment Research Centers. Dr. Hurlbert received his undergraduate degree in biochemistry from the University of Kansas and received his Ph.D. in pharmacology from the University of Colorado Health Sciences Center. He completed his training with a postdoctoral fellowship at New York University Medical Center, Skirball Institute of Biomolecular Medicine. After completing his training, Dr. Hurlbert transitioned to the nonprofit grant-making sector first at the Juvenile Diabetes Research Foundation (JDRF) and then joined Avon in 2004. |
| |
 |
Catherine Quinn
Catherine Quinn, is the Former Executive Director of the California Health Collaborative in Fresno, California. She holds a B.A. from California State University, Fresno and a Master of Public Administration, from University of San Francisco. Ms. Quinn has provided steadfast leadership to community health efforts in the Central Valley, and throughout the state, for over 20 years. She is passionately committed to reducing disparities in health access. Her professional affiliations include; American Public Health Association, (APHA), American Jail Association (AJA), American Corrections Association (ACA), National Correctional Industries Association (NCIA), and Lexington Who’s Who, Lifetime member. |
| |
 |
Laura Esserman, Ph.D.
|
| |
 |
Susan Love, MD, MBA
Susan M Love, MD, MBA has dedicated her professional life to the eradication of breast cancer. As President of the Dr. Susan Love Research Foundation, she oversees an active $4 million dollar research program centered on breast cancer cause and prevention. She is also a Clinical Professor of Surgery at UCLA’s David Geffen School of Medicine.
Dr. Susan Love is best known as a trusted guide to women worldwide through her books and the Foundation website. The completely revised fourth edition of Dr. Susan Love’s Breast Book termed “the bible for women with breast cancer” by The New York Times; was released October 2005, and the 5th edition will be coming out in 2010.
A true visionary, Susan Love’s most recent project, the Love/Avon Army of Women, is a creative Internet solution to partner women and scientists in order to accelerate basic translational research.
Dr. Love received her medical degree from SUNY Downstate Medical Center in New York, did her surgical training at Boston’s Beth Israel Hospital. She founded the Faulkner Breast Center in Boston and the Revlon UCLA Breast Center in Los Angeles. She has a business degree from the Executive MBA program at UCLA’s Anderson School.
www.dslrf.org
www.armyofwomen.org |
|
 |
Elly Cohen, Ph.D.
Elly Cohen has been associated with BreastCancerTrials.org almost from its beginning, guiding it from "idea" to regional Bay Area pilot, and most recently to nationwide service. She is currently Program Director of BreastCancerTrials.org and Senior Analyst with the University of California San Francisco (UCSF) Center of Excellence for Breast Cancer Care and. Elly participates in workshops designed to increase patient awareness about clinical trials and national efforts to create standards for clinical trial eligibility criteria.
Elly earned a bachelor's degree in Biology from Brooklyn College and a PhD in Pathology from Cornell University. Earlier in her career, she was a research neurobiologist and Adjunct Assistant Professor of Anatomy at UCSF. Elly has published papers in developmental neurobiology and the neurobiology of pain.
Elly is a breast cancer survivor. |
 |
Anna H. Wu
|
 |
Gina Solomon, M.D., M.P.H.
Gina Solomon is a Senior Scientist at the Natural Resources Defense Council (NRDC) and an Associate Clinical Professor of Medicine at the University of California at San Francisco (UCSF) where she is also the Director of the Occupational and Environmental Medicine Residency Program and the Associate Director of the UCSF Pediatric Environmental Health Specialty Unit. Her work has included over 40 scientific papers, book chapters, and reports on air pollution, pesticides, global warming, and other environmental and occupational threats to health. Dr. Solomon serves on the U.S. EPA Science Advisory Board Drinking Water Committee, the National Toxicology Program Board of Scientific Counselors, and the California Scientific Guidance Panel for biomonitoring. Dr. Solomon attended medical school at Yale and did her postgraduate training in internal medicine, public health, and occupational and environmental medicine at Harvard. |
 |
Megan Schwarzman, M.D., M.P.H.
Dr. Schwarzman’s work focuses on endocrine disrupting substances, reproductive environmental health, U.S. and European chemicals policy, and the implications for human health and the environment of the production, use and disposal of chemicals and products. She is a research scientist at the Center for Occupational and Environmental Health (COEH), in UC Berkeley’s School of Public Health, and Associate Director of Health and Environment for the interdisciplinary Berkeley Center for Green Chemistry. She earned her medical degree from the University of Massachusetts, completed her specialty training in Family Medicine at the University of California, San Francisco, and earned a master’s of public health from the University of California, Berkeley. Dr. Schwarzman also practices medicine part time at San Francisco General Hospital. |
 |
Sarah Janssen, M.D., Ph.D., M.P.H.
Dr. Sarah Janssen is a Senior Scientist in the Health and Environment Program of the Natural Resources Defense Council (NRDC). In her capacity as a Scientist with NRDC, Dr. Janssen provides scientific expertise for policy and regulatory decisions on a number of toxic chemicals, including hormone-disrupting substances which interfere with fertility and reproduction. Her work has included research on flame retardants, cosmetics, plastics and plasticizers, breast cancer and threats to adult reproductive health and child development. She is board-certified in Preventive Medicine with a subspecialty in Occupational and Environmental Medicine. Dr. Janssen is also an Assistant Clinical Professor at the University of California, San Francisco in the Division of Occupational and Environmental Medicine and works part time at Kaiser Permanente of Northern California. She is also a member of the Executive Committee of the San Francisco Bay Area chapter of Physicians for Social Responsibility. Dr. Janssen completed her MD and PhD in Molecular and Integrative Physiology at the University of Illinois, Urbana-Champaign in 2001. She did her residency training at the University of California, San Francisco which included a MPH in Environmental Health Sciences from the University of California, Berkeley. Dr. Janssen is the author of numerous peer-reviewed publications and book chapters. |
 |
Dale Johnson, Ph.D.
Dale Johnson is an Adjunct Professor in Molecular Toxicology at University of California, Berkeley where he teaches Computational Toxicology and is on the affiliated faculty of the Berkeley Center for Green Chemistry. Dr. Johnson is also a member of the Green Ribbon Science Panel for the State of California green chemistry initiatives and the expert panel for the California Breast Cancer and Chemicals Policy Project. He is also President & CEO of Emiliem, Inc. a biotechnology company focused on molecular targeted therapies and diagnostics. He has over 30 years experience in biopharmaceutical research and development activities where he has led and managed small units in start-up companies to multi-national groups in large corporations. Prior to Emiliem, he served as VP, Drug Assessment & Development at Chiron Corporation and previously VP, Preclinical Development. Prior R&D and executive positions include: Eos Biotechnology, Lederle (American Cyanamid), International Research and Development Corp. (a preclinical CRO), and Hoechst-Roussel Pharmaceuticals Inc. He received BS, PharmD, and PhD (Toxicology) degrees from the University of Michigan where he was an AFPE Fellow. He is a Diplomate of the American Board of Toxicology and co-editor of the journal The Chemistry of Metabolic and Toxicological Processes, Current Opinion in Drug Discovery & Development. |
 |
Shanaz H. Dairkee, Ph.D.
Shanaz H. Dairkee, Ph.D. is a Senior Scientist at the California Pacific Medical Center Research Institute where she leads a translationally focused research
program in breast cancer. Her laboratory is committed to the application of clinically derived model systems for studying Cellular and Molecular Changes in
Breast Cancer, and has published groundbreaking work in this field. This research aims to improve tumor targeting and prevention through a better
understanding of basic tumor biology. Dr. Dairkee received her doctorate in Human Genetics and Development from Columbia University in the City of
New York. She did postdoctoral research at the University of California, Berkeley and remained on the research faculty of the Dept. of Molecular Biology to pursue
the development of high throughput methodologies for the detection of cancer associated cellular changes. She continued research in this area at the Lawrence
Berkeley National Laboratory. Dr. Dairkee has received grant awards from the National Cancer Institute, U.S. Environmental Protection Agency, California
Breast Cancer Research Program, the biotech industry, and private foundations. She currently serves in the NIH scientific review process for extramural funding
in the area of tumor progression and metastasis. Ongoing research in her group includes the application of cells from high-risk individuals to investigate the
functional interaction between genes and environmental chemical exposure in cancer development and progression. Among many others, a unique resource
developed by her laboratory includes a vast repository of live, interactive cells from clinical samples to foster multi disciplinary work involving direct
experimentation with malignant human tissue. |
 |
Lauren Zeise, Ph.D.
Dr. Lauren Zeise is chief of the Reproductive and Cancer Hazard Assessment Branch of the California Environmental Protection Agency. She oversees or is otherwise involved in a variety of California's risk assessment activities, including cancer and reproductive toxicant assessments; development of frameworks and methodologies for assessing cumulative impact, nanotechnology, green chemistry/safer alternatives, and susceptible populations; the California Environmental Contaminant Biomonitoring Program; and health risk characterizations for environmental media, food, fuels and consumer products. Dr. Zeise's research focuses on human interindividual variability, dose response, uncertainty and risk. She was the 2008 recipient of the Society of Risk Analysis’s Outstanding Practitioners Award and is a National Associate of the National Academy of Science’s National Research Council (NRC). She has served on various advisory boards and committees of the Environmental Protection Agency, Office of Technology Assessment, World Health Organization, and National Institute of Environmental Health Sciences. She has also served on a numerous NRC and Institute of Medicine committees and boards, including the committees that produced Toxicity Testing in the 21st Century: A Vision and Strategy, Science and Decisions: Advancing Risk Assessment, and Understanding Risk: Informing Decisions in a Democratic Society. Dr. Zeise received her Ph.D. from Harvard University. |
